Explore Dr. Retzler’s HormoneSynergy® Longevity Medicine Resource Library

Intestinal Permeability and “Leaky Gut”: What the Science Actually Shows

Medical illustration showing intestinal epithelial cells, tight junctions, the mucus layer, and a localized area of increased permeability.
One-Minute Read:

Intestinal permeability describes how the digestive tract controls movement from the gut into the body. The intestinal lining must absorb nutrients, water, and electrolytes while limiting inappropriate contact with microbes, toxins, and large food-derived molecules.

Increased permeability is a real and measurable feature of conditions including celiac disease, inflammatory bowel disease, gastrointestinal infections, and severe intestinal injury. It may also occur in subsets of people with irritable bowel syndrome and metabolic disease. In many cases, it remains unclear whether the barrier change is a cause, a consequence, or both.

“Leaky gut syndrome” is different. It is not a standardized medical diagnosis, and symptoms such as bloating, fatigue, food reactions, joint pain, or brain fog cannot establish that the intestinal barrier is abnormal. Commercial zonulin, stool, and food-sensitivity panels are often promoted with more confidence than their validation supports.

The intestinal lining is dynamic and capable of repair. The most useful approach is to identify and treat established causes, improve dietary quality, avoid unnecessary intestinal irritants, and support sleep, activity, and metabolic health.

The digestive tract performs a difficult balancing act. It must remain open enough to absorb nutrients and water while being selective enough to manage constant exposure to food, microorganisms, and microbial products.

This selectivity is what clinicians and researchers mean by intestinal permeability. It is a normal physiological property, not automatically a disease.

Problems can develop when the barrier becomes abnormally permeable, the intestinal lining is injured, or immune regulation at the mucosal surface is disrupted. Increased permeability is well documented in several diseases. What remains less certain is how often it acts as the initiating cause of symptoms outside the digestive tract.

This article is part of the HormoneSynergy® Gut Health, Microbiome, and Longevity Medicine Guide.


What Is Intestinal Permeability?

Intestinal permeability describes the movement of substances across the intestinal lining. Some movement is necessary and beneficial. Digested nutrients, water, and electrolytes must cross the epithelium to enter circulation.

Substances can move through two principal routes:

  • Transcellular transport: movement through intestinal cells using channels, transporters, vesicles, and other controlled mechanisms.
  • Paracellular transport: movement through the spaces between neighboring cells, regulated largely by junctional proteins.

Permeability also varies along the digestive tract. The stomach, small intestine, and colon have different functions, microbial populations, mucus structures, and transport requirements. A single test result cannot necessarily describe the entire gastrointestinal barrier.

When researchers refer to increased intestinal permeability, they generally mean that substances cross the barrier more readily than expected under defined testing conditions.


The Intestinal Barrier Is More Than Tight Junctions

Tight junctions are important, but the barrier is a coordinated biological system rather than a row of cells held together by one type of protein.

Mucus

Goblet cells produce mucus that creates physical separation between intestinal microbes and the epithelial surface. The mucus layer differs between the small intestine and colon and is continually renewed.

Intestinal Epithelial Cells

A single layer of epithelial cells performs absorption, secretion, immune signaling, and physical containment. These cells turn over rapidly, allowing the lining to repair ordinary wear and minor injury.

Cell Junctions

Tight junctions contain proteins including claudins, occludin, and junctional adhesion molecules. They regulate movement between epithelial cells. Adherens junctions and desmosomes provide additional structural support.

Immune Defenses

Secretory IgA, immune cells, antimicrobial peptides, and organized lymphoid tissue help regulate microbial contact without producing unnecessary inflammation.

The Microbiome

Resident microbes compete with potential pathogens, interact with the mucus layer, and produce metabolites that influence epithelial and immune function. Microbial composition alone does not determine whether the barrier is healthy, but it contributes to the surrounding environment.

Blood Flow and the Nervous System

Healthy circulation supports tissue repair, while the enteric and autonomic nervous systems influence motility, secretion, blood flow, and immune activity. The intestinal barrier is therefore connected with the rest of the body rather than functioning as an isolated wall.


What Can Increase Intestinal Permeability?

Increased permeability can develop through several different mechanisms. Some causes produce temporary changes, while others create ongoing inflammation or tissue injury.

Celiac Disease

In genetically susceptible people, gluten exposure activates an immune response that damages the small-intestinal lining. Increased permeability is part of the disease process, but celiac disease requires appropriate antibody testing and, in some cases, endoscopic biopsy.

Anyone being evaluated for celiac disease should generally continue eating gluten until testing is completed. Starting a gluten-free diet first can produce misleading results.

Inflammatory Bowel Disease

Crohn’s disease and ulcerative colitis involve immune-mediated intestinal inflammation. Barrier disruption may both reflect active disease and allow further contact between microbial products and immune cells.

Gastrointestinal Infection

Bacterial, viral, and parasitic infections can injure epithelial cells, alter tight-junction regulation, and trigger inflammation. Barrier function often improves as the infection resolves, although some people develop persistent symptoms afterward.

Medications

Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen can injure the gastrointestinal lining, particularly with frequent or high-dose use. Chemotherapy, radiation, and certain other treatments can also affect epithelial integrity.

Proton-pump inhibitors may alter microbial and intestinal conditions, but they remain appropriate and important medications for many patients. They should not be stopped solely because an online source claims they cause leaky gut.

Alcohol

Heavy or repeated alcohol exposure can affect tight-junction regulation, microbial composition, intestinal inflammation, and liver function. Individual susceptibility and dose matter.

Critical Illness and Reduced Blood Flow

Sepsis, major burns, trauma, intestinal ischemia, and other severe illnesses can cause substantial barrier injury. These situations are clinically different from the low-grade permeability discussed in wellness marketing.

Dietary and Metabolic Factors

Diets low in fiber and high in ultra-processed foods may create a less favorable microbial and metabolic environment. Obesity, insulin resistance, and fatty liver disease have also been associated with permeability-related markers.

Association does not establish that the barrier abnormality caused the metabolic condition. Metabolic inflammation may itself affect barrier function, creating a potentially bidirectional relationship.


Is “Leaky Gut Syndrome” a Medical Diagnosis?

Not in the way the term is commonly used online.

Increased intestinal permeability is a recognized physiological finding. “Leaky gut syndrome” is often used as a broad diagnosis for symptoms that may include:

  • bloating or abdominal discomfort
  • fatigue
  • brain fog
  • headaches
  • joint pain
  • skin symptoms
  • food reactions
  • mood changes

These symptoms are real, but none is specific to intestinal permeability. They can occur with celiac disease, inflammatory bowel disease, irritable bowel syndrome, food allergy, lactose intolerance, thyroid disease, anemia, sleep disorders, medication effects, mood disorders, and many other conditions.

Labeling the symptoms “leaky gut” without evaluating more established explanations can delay diagnosis and lead to unnecessarily restrictive diets or expensive supplement protocols.


The Microbiome and Barrier Function

The microbiome influences the barrier through competition with pathogens, microbial metabolites, immune education, and interactions with mucus and epithelial cells.

Short-chain fatty acids are among the best-studied microbial metabolites. Butyrate can serve as an energy source for colon cells and has been linked with mucus production, immune regulation, and tight-junction function in experimental research.

The relationship is not as simple as dividing bacteria into universally “good” and “bad” categories. The effect of a microbe depends on its strain, location, surrounding community, available nutrients, and the health of the host.

Stool testing can identify organisms or genes found in a stool sample. It does not directly measure the integrity of the small-intestinal lining, tight junctions, or the amount of microbial material entering circulation.

Explore Butyrate and Short-Chain Fatty Acids for a deeper look at microbial fermentation and barrier physiology.


Intestinal Permeability, Inflammation, and Metabolic Health

If microbial components move beyond the intestinal lumen, they may interact with immune cells and activate inflammatory pathways. Lipopolysaccharide, or LPS, is one microbial product studied in connection with insulin resistance and metabolic inflammation.

Animal research provides strong mechanistic evidence that gut-derived microbial signals can affect metabolism. Human studies have identified associations among permeability-related measurements, visceral fat, fatty liver disease, insulin resistance, and cardiovascular risk.

The direction and clinical importance of these relationships remain uncertain. A permeability-related biomarker cannot establish that the gut caused a person’s metabolic disease.

Standard cardiometabolic measurements remain more actionable. These include blood pressure, waist circumference, body composition, fasting glucose, A1C, fasting insulin when appropriate, triglycerides, HDL, ApoB, and liver health.

Read LPS and Metabolic Endotoxemia for the evidence and testing limitations surrounding this pathway.


What About Irritable Bowel Syndrome?

Some people with irritable bowel syndrome, particularly diarrhea-predominant or post-infectious IBS, demonstrate increased permeability in research studies. The finding is not universal.

A recent review found evidence of increased permeability in a majority of studies involving diarrhea-predominant IBS, but much less consistently in constipation-predominant IBS. Differences in testing methods and patient selection make direct comparisons difficult.

IBS remains a disorder of gut-brain interaction involving motility, visceral sensitivity, microbial factors, immune signaling, diet, stress physiology, and other mechanisms. It should not automatically be renamed leaky gut.


How Is Intestinal Permeability Tested?

Oral Sugar Tests

Research and selected specialty centers may use orally administered sugar probes. The patient drinks a solution containing molecules of different sizes, and urine or blood is collected afterward.

The lactulose-to-mannitol ratio has traditionally been used to assess small-intestinal permeability. Other sugar combinations can examine different regions of the gastrointestinal tract.

Results can be affected by gastric emptying, intestinal transit, kidney function, urine collection, hydration, recent food intake, medications, and laboratory methods. Protocols and reference ranges are not fully standardized.

Zonulin

Zonulin-related signaling has a legitimate role in intestinal biology, particularly in celiac-disease research. Commercial testing is more problematic.

Studies have found that widely used zonulin ELISA kits may not measure pre-haptoglobin 2, the protein originally identified as zonulin. Serum results have also failed to correlate reliably with direct permeability testing in healthy adults.

A commercial zonulin result should therefore not be treated as a stand-alone diagnosis of leaky gut.

Stool Markers

Fecal calprotectin can help identify intestinal inflammation and is clinically useful in the evaluation and monitoring of inflammatory bowel disease. It does not directly measure permeability.

Secretory IgA, microbiome profiles, digestive markers, and other stool measurements may answer different questions. None provides a complete measurement of barrier function.

Food-IgG Panels

Food-specific IgG commonly reflects exposure and immune recognition rather than intolerance or intestinal leakage. Broad IgG food panels are not accepted diagnostic tests for food allergy and frequently lead to unnecessary food avoidance.

Biopsy

Endoscopic biopsy can identify tissue inflammation, villous injury, microscopic colitis, and other pathology. It is ordered when a recognized gastrointestinal condition is suspected, not as a routine test for a nonspecific leaky-gut diagnosis.


What Supports Intestinal-Barrier Recovery?

The intestinal epithelium renews itself rapidly and can recover when the source of injury is addressed. Treatment should begin with the cause rather than a generic protocol.

Treat Established Disease

A strict gluten-free diet treats celiac disease. Appropriate anti-inflammatory or immune-directed therapy treats inflammatory bowel disease. Antimicrobial treatment may be needed for selected infections. These interventions are more important than adding a generalized gut-repair supplement.

Review Medication Exposure

Frequent NSAID use, unnecessary antibiotics, and other potentially relevant medications should be reviewed with a clinician. Necessary prescriptions should not be stopped without medical guidance.

Build a Nutrient-Dense Diet

A plant- and protein-forward Mediterranean pattern provides fiber, polyphenols, essential fats, vitamins, minerals, and sufficient protein for tissue maintenance.

More fiber is not appropriate in every situation. Active inflammatory bowel disease, intestinal strictures, severe gastroparesis, or significant fermentative symptoms may require temporary modification.

Support Microbial Fermentation

When tolerated, a range of plant fibers can support microbial production of short-chain fatty acids. Variety and gradual progression are generally more useful than chasing one supposedly perfect prebiotic.

Limit Heavy Alcohol Use

Reducing alcohol exposure can benefit intestinal integrity, liver health, sleep, blood pressure, and metabolic function.

Exercise and Protect Sleep

Physical activity and sufficient sleep support insulin sensitivity, immune regulation, intestinal motility, and overall resilience. Their value does not depend on proving a specific permeability mechanism.

Use Supplements for Defined Reasons

Supplements may support selected aspects of digestive physiology, but they should not be presented as universal treatments for intestinal permeability. The formulas below serve different purposes and should be chosen according to symptoms, diet, tolerance, and the broader clinical picture.

Targeted Gut-Lining Support

RetzlerRx® Glutamine Synergy is a powdered formula providing L-glutamine with deglycyrrhizinated licorice and aloe. Glutamine is an important fuel source for intestinal cells and has been studied in selected conditions involving intestinal stress or injury. Evidence varies by population, so it should not be described as a universal way to “seal” the gut.*

RetzlerRx® Leaky Gut Support provides a capsule-based combination of glutamine, arabinogalactan, DGL, and aloe. It may be considered when someone prefers capsules and wants a broader formula combining intestinal-tissue, prebiotic, and digestive-comfort support.*

Serum-Derived Immunoglobulins

Serum-derived bovine immunoglobulins remain primarily within the gastrointestinal tract, where they may bind selected microbial antigens and support normal mucosal immune function. Human evidence is most relevant to selected chronic loose-stool and enteropathy populations rather than generalized “leaky gut.”*

For a practical comparison of delivery forms, dosing, and ingredients, see MegaIgG2000 Powder vs. Capsules.

Spore-Based Probiotic Support

MegaSporeBiotic™ is a spore-based probiotic formulated to survive passage through the upper digestive tract. Selected studies have examined this type of formulation in relation to microbial diversity and intestinal-barrier markers. Response and tolerance vary, and a probiotic should not replace evaluation for celiac disease, inflammatory bowel disease, infection, or another established gastrointestinal condition.*

Whole-Food Polyphenol and Prebiotic Support

Big Bold Health Microbiome Rejuvenate is not a conventional probiotic. It uses sprouted Himalayan Tartary buckwheat to provide whole-food polyphenols, resistant starches, and prebiotic fibers intended to nourish the existing microbiome.*

This type of formula may be considered for broader dietary and microbiome support, particularly when the objective is to provide fermentable substrates and plant compounds rather than introduce additional bacterial strains. People with significant bloating or sensitivity to fermentable carbohydrates may need to begin cautiously.*

These products are options, not a mandatory stack. Most people would not need all of them at once. Selection should reflect the specific objective, preferred delivery form, dietary pattern, gastrointestinal tolerance, and any underlying diagnosis.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent disease. Supplements should support, not replace, appropriate medical evaluation and treatment.


When Gastrointestinal Symptoms Need Evaluation

Medical evaluation is particularly important when digestive symptoms are persistent or accompanied by:

  • blood in the stool or black stool
  • unexplained weight loss
  • iron-deficiency anemia
  • fever
  • recurrent vomiting
  • nighttime diarrhea or pain
  • difficulty swallowing
  • a family history of celiac disease, inflammatory bowel disease, or gastrointestinal cancer
  • new symptoms later in adulthood

These findings should not be managed solely with elimination diets, probiotics, or online gut-repair programs.


A HormoneSynergy® Perspective

Intestinal permeability is legitimate physiology. The broad syndrome often sold under the same name is much less clearly defined.

At HormoneSynergy®, gut-barrier health is considered within a larger clinical picture that may include gastrointestinal symptoms, diet, medication exposure, metabolic health, inflammation, sleep, stress physiology, and appropriate conventional testing.

The aim is to identify the most likely cause, treat conditions that can be diagnosed, and use nutrition or supplements with a clear purpose. That approach is less dramatic than promising to seal a leaky gut, but it is more likely to produce useful and measurable care.


Frequently Asked Questions

Is leaky gut real?

Increased intestinal permeability is a real physiological finding associated with several diseases. “Leaky gut syndrome,” used as a broad explanation for nonspecific symptoms, is not a standardized medical diagnosis.

What are the symptoms of intestinal permeability?

There is no symptom pattern specific to increased permeability. Bloating, diarrhea, abdominal pain, fatigue, and food-related symptoms may occur, but they have many other possible causes.

What is the most reliable leaky-gut test?

Oral sugar-probe testing is used in research and selected clinical settings, but methods and reference ranges vary. No routine commercial test can diagnose every form of intestinal-barrier dysfunction.

Is zonulin a reliable leaky-gut marker?

Commercial zonulin testing has important limitations. Common assays may not measure the protein originally identified as zonulin, and serum levels do not consistently correlate with direct permeability measurements.

Does a stool test measure intestinal permeability?

No. Stool testing can evaluate inflammation, microbes, digestion, or other gastrointestinal features, depending on the test. It does not directly measure movement across the intestinal lining.

Can probiotics repair leaky gut?

Certain strains may support aspects of barrier or immune function in selected populations. Effects are strain specific, and probiotics are not a universal treatment for intestinal permeability.

How long does the intestinal barrier take to heal?

The epithelium renews rapidly, but recovery depends on the cause. Temporary injury may improve quickly, while celiac disease, inflammatory bowel disease, infection, medication injury, or ongoing alcohol exposure may require longer and condition-specific treatment.

Should gluten be removed to heal the gut?

Gluten must be strictly avoided in celiac disease. It does not need to be universally removed for intestinal health. Celiac testing should generally be completed before beginning a gluten-free diet.


Selected References

  • König J, Wells J, Cani PD, et al. Human intestinal barrier function in health and disease. Clinical and Translational Gastroenterology. 2016;7:e196.
  • Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability: a new target for disease prevention and therapy. BMC Gastroenterology. 2014;14:189.
  • Khoshbin K, Khanna L, Maselli D, et al. Development and validation of a test for leaky gut small intestinal and colonic permeability using sugars in healthy adults. Gastroenterology. 2021;161(2):463-475.e13.
  • Scheffler L, Crane A, Heyne H, et al. Widely used commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Frontiers in Endocrinology. 2018;9:22.
  • Tatucu-Babet OA, Forsyth A, Owen E, et al. Serum zonulin measured by enzyme-linked immunosorbent assay may not be a reliable marker of small intestinal permeability in healthy adults. Nutrition Research. 2020;78:82-92.
  • Grover M, et al. Intestinal permeability in disorders of gut-brain interaction. Gastroenterology. 2025.

This article is for educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment. Persistent or concerning gastrointestinal symptoms should be assessed by an appropriately qualified clinician.

Longevity Medicine Education Series
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.

Return to the Longevity Medicine Guide →

Leave a comment

Name .
.
Message .

Please note, comments must be approved before they are published